» Articles » PMID: 26852880

Carpal Tunnel Syndrome: a Common Initial Symptom of Systemic Wild-type ATTR (ATTRwt) Amyloidosis

Overview
Journal Amyloid
Specialty Biochemistry
Date 2016 Feb 9
PMID 26852880
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Systemic wild-type ATTR (ATTRwt) amyloidosis is a prevalent aging-related disorder. However, a limited number of systemic ATTRwt amyloidosis patients have been diagnosed antemortem, and therefore, the prevalence of ATTRwt is underestimated. Here, we investigated clinical findings of a series of systemic ATTRwt amyloidosis patients with antemortem diagnosis.

Methods: Thirty-one consecutive patients diagnosed with systemic ATTRwt amyloidosis at Shinshu University Hospital were included in this study. Systemic ATTRwt amyloidosis was diagnosed based on proven ATTR amyloid deposition in biopsy specimens and confirmation of wild-type TTR genotype.

Results: The systemic ATTRwt amyloidosis patients consisted of 24 men and seven women, and mean age of onset was 69.8 ± 9.0 years. The most common initial symptom was carpal tunnel syndrome (CTS, 17 patients), followed by heart failure symptoms (14 patients). The mean age at diagnosis was 74.5 ± 8.3 years and the duration of illness from onset to diagnosis was 5.4 ± 4.4 years. Cardiogenic embolism and renal dysfunction are also frequently seen during the course of the disease.

Conclusions: CTS is the most common initial symptom of systemic ATTRwt amyloidosis. Our results suggest the possibility of systemic ATTRwt amyloidosis diagnosis at an early stage by carefully examining patients with CTS.

Citing Articles

Evolving knowledge of red flag clinical features associated with TTR p.(Val142Ile) in a diverse electronic health-record-linked biobank.

Kontorovich A, Benson C, McClellan A, Belbin G, Kenny E, Abul-Husn N Genet Med. 2024; 27(3):101346.

PMID: 39698805 PMC: 11890965. DOI: 10.1016/j.gim.2024.101346.


Amyloids and the Heart: An Update.

Triposkiadis F, Briasoulis A, Xanthopoulos A J Clin Med. 2024; 13(23).

PMID: 39685666 PMC: 11642274. DOI: 10.3390/jcm13237210.


Diagnosing AL and ATTR Amyloid Cardiomyopathy: A Multidisciplinary Approach.

Aus dem Siepen F, Hansen T J Clin Med. 2024; 13(19).

PMID: 39407933 PMC: 11477302. DOI: 10.3390/jcm13195873.


Management Targeted Genetic Evaluation of an Idiopathic Neuropathy Cohort Through ATTRv Amyloidosis Screening.

Fisher K, Diaz S, Gelblum J, Brock C, Suresh N, Towne M HCA Healthc J Med. 2024; 5(4):405-413.

PMID: 39290488 PMC: 11404592. DOI: 10.36518/2689-0216.1557.


Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy.

Garcia-Pavia P, Damy T, Piriou N, Barriales-Villa R, Cappelli F, Bahus C ESC Heart Fail. 2024; 11(6):4314-4324.

PMID: 39210606 PMC: 11631301. DOI: 10.1002/ehf2.14971.